Lewis Diuguid

February 27, 2014

Congressional hearing on Alzheimer’s is a positive step toward an eventual cure

It’s not all talk. The congressional hearings on Alzheimer’s disease help to humanize the concerns about the mind-robbing, chronic ailment, which could lead to better funding for research and an eventual cure.

The congressional hearing Wednesday inviting testimony from people about Alzheimer’s disease was a step in the right direction toward finding a cure.

If members of Congress hear from enough Americans, their family members and researchers who are desperate to find a cause and finally a cure for the mind-robbing disease, then they are more likely to increase the funding to make a breakthrough possible.

More than 5 million Americans currently suffer from Alzheimer’s. That number is expected to increase as more baby boomers age.

The disease cost the United States about $203 billion last year, and of that $142 billion came from Medicare and Medicaid. If members of Congress hear from enough people who put a compelling human face on this growing problem, they are more likely to increase the funding for research.

Former Rep. Dennis Moore of Kansas certainly helped on Wednesday with his testimony. The hearings just have to continue until a cure is found.

Related content



Editor's Choice Videos